Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Benjamin Cousins

Plastic Surgery Miami Beach, FL Medical Doctor

NPI 1780708909 CMS profile 262621

4308 Alton Rd Ste 720, Miami Beach, FL 33140

Open in the dashboard

General payments

$9,392

136 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Benjamin Cousins of Miami Beach, FL is reported in the CMS Open Payments database as having received $9,392 across 136 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 82nd percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,824 30
2024 General $1,439 23
2023 General $1,929 27
2022 General $794 15
2021 General $824 19
2020 General $914 13
2019 General $670 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Benjamin Cousins
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Benjamin Cousins were reported at $2,824. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Benjamin Cousins Plastic Surgery median Middle half National median
2019 $670 $371 $122–$1,483 $163
2020 $914 $158 $52–$438 $114
2021 $824 $249 $87–$752 $132
2022 $794 $274 $102–$793 $149
2023 $1,929 $299 $113–$891 $160
2024 $1,439 $361 $124–$1,062 $164
2025 $2,824 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Mentor Worldwide LLC $1,076 14 payments
  2. TELA Bio, Inc. $752 13 payments
  3. AbbVie, Inc. $711 15 payments
  4. Musculoskeletal Transplant Foundation Inc. $710 6 payments
  5. Sientra, Inc. $595 13 payments
  6. Integra LifeSciences Corporation $520 6 payments
  7. Stryker Corporation $500 5 payments
  8. Allergan Inc. $461 11 payments
  9. Motiva USA, LLC $420 3 payments
  10. Becton, Dickinson and Company $351 2 payments
  11. Other $3,295 48 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $9,392 136 payments
Products named General payments · program years 2019–2025
  1. MENTOR MemoryGel Resterilizable Gel Sizer $1,007 12 payments
  2. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $595 13 payments
  3. OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) $518 7 payments
  4. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $505 5 payments
  5. Motiva Implant Matrix $420 3 payments
  6. CORTIVA ALLOGRAFT DERMIS $336 2 payments
  7. BOTOX $334 17 payments
  8. SPY-PHI SYSTEM $323 2 payments
  9. DuraSorb Monofilament Mesh $313 2 payments
  10. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $310 3 payments
  11. Other $5,646 100 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 37 billing codes

Paid by Medicare

$13,207

Medicare's payments for the services billed

Medicare patients

32

Average age 77

Services billed

90

17 women, 15 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Depression 56%
Arthritis 53%
Diabetes 44%
Cancer 41%
Ischemic heart disease 38%
Chronic kidney disease 34%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Xeomin
  • MERZ NORTH AMERICA, INC. $33
$33 — —
BOTOX
  • AbbVie, Inc. $7
$7 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

136 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record